Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hirofumi Abo
Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients With Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase‐R)
Oncologist
Cancer Research
Medicine
Oncology
Related publications
Efficacy and Safety of Chemotherapy in Older Versus Non-Older Patients With Advanced Gastric Cancer: A Real-World Data, Non-Inferiority Analysis
Journal of Geriatric Oncology
Gerontology
Geriatrics
Oncology
Olaparib in the Therapy of Advanced Ovarian Cancer: First Real World Experiences in Safety and Efficacy From China
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Real-World Efficacy and Safety of Eribulin in Advanced and Pretreated HER2-negative Breast Cancer in a Spanish Comprehensive Cancer Center
BMC pharmacology & toxicology
Medicine
Pharmacology
P1.01-28 Impact of Afatinib Dosing on Safety and Efficacy Real-World in Patients With EGFR Mutation-Positive Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Hyperthermic Intraperitoneal Chemotherapy Does Not Improve Survival in Advanced Ovarian Cancer
Cancer
Cancer Research
Oncology
The Efficacy and Safety of Different Pharmacological Interventions for Patients With Advanced Biliary Tract Cancer: A Network Meta-Analysis
Oncotarget
Oncology
Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Comprehensive Approaches to Managing Delirium in Patients With Advanced Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
A Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of CXD101 in Patients With Advanced Cancer
Cancer
Cancer Research
Oncology
